The feasibility of neoadjuvant high-dose
β
Fikret Arpaci; Selmin Ataergin; Ahmet Ozet; Kaan Erler; Mustafa Basbozkurt; Ayha
π
Article
π
2005
π
John Wiley and Sons
π
English
β 144 KB
π 1 views
## Abstract ## BACKGROUND The primary and secondary objectives of the current study were to improve the β₯ 90% tumor necrosis rate and assess the toxicity profile of the neoadjuvant highβdose chemotherapy (HDC) regimen, respectively. ## METHODS Twentyβtwo patients with AJCC Stage IIB highβgrade o